Agios Pharmaceuticals, Inc. (AGIO)
35.14
+0.22
(+0.63%)
USD |
NASDAQ |
Apr 17, 16:00
35.13
-0.01
(-0.03%)
After-Hours: 20:00
Agios Pharmaceuticals SG&A Expense (Quarterly) : 51.61M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| Biogen, Inc. | 682.50M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Apellis Pharmaceuticals, Inc. | 147.10M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |